NCT04363333

Obstructive Sleep Apnea & Covid-19 Outcomes

Impact of Obstructive Sleep Apnea on Covid-19 Outcomes (OSACOVID-19 Study): A Prospective Observational Cohort Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 320 (actual)
• Sponsor: Koç University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Covid-19 infection is an on-going pandemic with worse diagnosis in adults with comorbid conditions such as hypertension and cardiopulmonary diseases. Obstructive sleep apnea (OSA) is common in those comorbidities and may contribute to worse prognosis for the Covid-19 cases.

Detailed description

The investigators' primary aim is to address the association between the high probability of having OSA and Covid-19 outcomes within 28 days of the hospitalization. Secondary outcomes will be conducting a polysomnography in cases with high probability of having OSA compared to those with low probability, approx. 4 months after the Covid-19 diagnosis, and re-evaluate the association of the verified OSA diagnosis and severity with the outcomes in the first 4 weeks as well as with the outcomes after 4 months.

Conditions

• COVID
• Obstructive Sleep Apnea
• Pneumonia

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Home Sleep Apnea Testing or In-hospital Polysomnography	Home Sleep Apnea Testing or In-hospital Polysomnography will be conducted 4 to 6 months after the Covid-19 diagnosis

Timeline

• Start date: 2020-04-27
• Primary completion: 2021-05-31
• Completion: 2021-07-31
• First posted: 2020-04-27
• Last updated: 2021-02-17

Locations

3 sites across 1 country: Turkey (Türkiye)